The FDA approved external trigeminal nerve stimulation (TNS) in 2019 as the first non-drug device for treating ADHD, ...
Novo Nordisk’s version of Wegovy in pill form represents the first-ever oral glucagon-like peptide-1 (GLP-1) receptor agonist ...
New federal guidance is expanding testing for cervical cancer with a self-collection method. Dr. Mara Gordon speaks to NPR about why this option might become popular for screening for HPV.
FDA-approved semaglutide drug is the first GLP-1 pill for weight loss available in the U.S., according to drugmaker Novo Nordisk.
“Since most physicians don’t know that this is an option, patients don’t know about it. It’s safe, effective, and puts the ...
Most weight loss drugs are FDA-approved for people with obesity or overweight with a weight-related health condition. A healthcare provider can help you find the best weight loss medication for you.
Comprehensive comparison of daily oral vs weekly injectable Wegovy following Novo Nordisk's January 2026 FDA approval of the ...
A new FDA-approved at-home test could help women test for cervical cancer earlier. These are today's mortgage and refinance ...
The Oura Ring isn’t FDA approved as a medical device. It’s considered a general wellness product. This means it’s designed ...
PRNewswire/ -- eMed Population Health, the leading digital health platform for GLP-1/GIP population health management, today announced it has been named a Novocare Recognized Care Provider delivering ...
Following Oral Wegovy Introduction, Consumer Analysis Examines Injectable vs Oral Semaglutide Pricing, Compounded Tirzepatide Access Through Direct Meds, and Three-Entity Telehealth Platform ...